Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Oxford Finance and Silicon Valley Bank Provide $30 Million Senior Credit Facility to Halozyme Therapeutics



   Oxford Finance and Silicon Valley Bank Provide $30 Million Senior Credit
                      Facility to Halozyme Therapeutics

PR Newswire

ALEXANDRIA, Va., Jan. 15, 2013

ALEXANDRIA, Va., Jan. 15, 2013 /PRNewswire/ -- On December 28, 2012, Oxford
Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to
life sciences and healthcare services companies, closed a $30 million round of
debt financing for Halozyme Therapeutics, Inc. (Halozyme).  Silicon Valley
Bank also participated in this transaction.  

"Oxford is very pleased to provide Halozyme capital to support its unique and
innovative portfolio of products that addresses therapeutic areas, including
diabetes, oncology and dermatology," said Christopher A. Herr, managing
director for Oxford Finance. "In addition to having an impressive and proven
technology, Halozyme has a management team with a great deal of expertise
developing and commercializing products that advance patient care."

"Working with companies like Halozyme that are innovating the patient
experience in areas like oncology and diabetes is particularly rewarding,"
said Michael White, senior relationship manager for Silicon Valley Bank's San
Diego office. "Our life science team is looking forward to continuing our long
and productive relationship with the Halozyme team, offering the financing,
flexibility and support the company needs to continue to develop its
products."

"We are pleased to be working with both Oxford and Silicon Valley Bank," said
Kurt Gustafson, chief financial officer of Halozyme Therapeutics. "This new
line of credit gives us access to additional capital that will help us advance
the development and commercialization of our novel proprietary therapeutics."

About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to
public and private life sciences and healthcare services companies worldwide.
For over 20 years, Oxford has delivered flexible financing solutions to its
clients, enabling these companies to maximize their equity by leveraging their
assets. In recent years, Oxford has originated nearly $2 billion in loans,
with lines of credit ranging from $500 thousand to $50 million. Oxford is
headquartered in Alexandria, Virginia, with additional offices in California,
Illinois, Massachusetts and North Carolina. For more information visit
www.oxfordfinance.com.  

About Silicon Valley Bank
Silicon Valley Bank is the premier bank for technology, life sciences,
cleantech, venture capital, private equity and premium wine businesses. SVB
provides industry knowledge and connections, financing, treasury management,
corporate investment and international banking services to its clients
worldwide through 27 U.S. offices and six international operations. (Nasdaq:
SIVB) www.svb.com.  
 
Silicon Valley Bank is the California bank subsidiary and the commercial
banking operation of SVB Financial Group. Banking services are provided by
Silicon Valley Bank, a member of the FDIC and the Federal Reserve System.  SVB
Financial Group is also a member of the Federal Reserve System.

 

SOURCE Oxford Finance LLC

Website: http://www.oxfordfinance.com
Contact: Shelly Davis, Oxford Finance LLC, +1-888-471-0174,
sdavis@oxfordfinance.com; or Carrie Merritt, Silicon Valley Bank,
+1-503-574-3705, cmerritt@svb.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement